American Century Companies Inc. lessened its stake in Innospec Inc. (NASDAQ:IOSP) by 17.4% in the 4th quarter, Holdings Channel reports. The firm owned 370,753 shares of the specialty chemicals company’s stock after selling 78,336 shares during the period. American Century Companies Inc.’s holdings in Innospec were worth $26,175,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of IOSP. C M Bidwell & Associates Ltd. acquired a new stake in Innospec during the 4th quarter worth $142,000. Victory Capital Management Inc. grew its holdings in Innospec by 33.4% during the 3rd quarter. Victory Capital Management Inc. now owns 3,629 shares of the specialty chemicals company’s stock worth $224,000 after acquiring an additional 909 shares during the period. SG Americas Securities LLC grew its holdings in Innospec by 130.5% during the 3rd quarter. SG Americas Securities LLC now owns 3,738 shares of the specialty chemicals company’s stock worth $230,000 after acquiring an additional 2,116 shares during the period. Cubist Systematic Strategies LLC grew its holdings in Innospec by 39.7% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 4,397 shares of the specialty chemicals company’s stock worth $288,000 after acquiring an additional 1,250 shares during the period. Finally, Crossmark Global Holdings Inc. acquired a new stake in Innospec during the 3rd quarter worth $302,000. Hedge funds and other institutional investors own 91.02% of the company’s stock.

A number of research firms have commented on IOSP. BidaskClub lowered shares of Innospec from a “hold” rating to a “sell” rating in a report on Thursday, January 25th. Zacks Investment Research lowered shares of Innospec from a “buy” rating to a “hold” rating in a report on Wednesday, January 10th. Johnson Rice raised shares of Innospec from a “hold” rating to an “accumulate” rating in a report on Tuesday, November 14th. Monness Crespi & Hardt lowered shares of Innospec from a “buy” rating to a “neutral” rating in a report on Thursday, November 9th. Finally, KeyCorp reaffirmed an “overweight” rating on shares of Innospec in a report on Thursday, November 9th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company’s stock. Innospec currently has a consensus rating of “Hold” and an average target price of $70.50.

Shares of Innospec Inc. (NASDAQ:IOSP) opened at $67.03 on Thursday. The company has a current ratio of 2.24, a quick ratio of 1.35 and a debt-to-equity ratio of 0.30. Innospec Inc. has a fifty-two week low of $54.10 and a fifty-two week high of $74.75. The company has a market cap of $1,605.15, a price-to-earnings ratio of 18.57 and a beta of 1.07.

Innospec (NASDAQ:IOSP) last released its earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.47 EPS for the quarter, topping analysts’ consensus estimates of $1.13 by $0.34. Innospec had a net margin of 7.45% and a return on equity of 15.05%. The firm had revenue of $353.80 million during the quarter. equities analysts forecast that Innospec Inc. will post 4.3 earnings per share for the current fiscal year.

In related news, VP Brian Watt sold 440 shares of the company’s stock in a transaction on Tuesday, November 21st. The shares were sold at an average price of $70.17, for a total value of $30,874.80. Following the completion of the transaction, the vice president now directly owns 30,730 shares of the company’s stock, valued at approximately $2,156,324.10. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Catherine Hessner sold 707 shares of the company’s stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $71.56, for a total transaction of $50,592.92. Following the completion of the transaction, the vice president now directly owns 25,791 shares of the company’s stock, valued at $1,845,603.96. The disclosure for this sale can be found here. Insiders sold a total of 24,366 shares of company stock valued at $1,743,891 in the last three months. 2.02% of the stock is owned by company insiders.

WARNING: This piece was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2018/02/15/innospec-inc-iosp-shares-sold-by-american-century-companies-inc.html.

Innospec Company Profile

Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.

Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP).

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.